GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invex Therapeutics Ltd (ASX:IXC) » Definitions » Investments And Advances

Invex Therapeutics (ASX:IXC) Investments And Advances : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Invex Therapeutics Investments And Advances?

Invex Therapeutics's Investments And Advances for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Invex Therapeutics Investments And Advances Historical Data

The historical data trend for Invex Therapeutics's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invex Therapeutics Investments And Advances Chart

Invex Therapeutics Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Investments And Advances
- - - -

Invex Therapeutics Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Investments And Advances Get a 7-Day Free Trial Premium Member Only - - - - -

Invex Therapeutics Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Invex Therapeutics (ASX:IXC) Business Description

Traded in Other Exchanges
N/A
Address
38 Rowland Street, Level 1, Subiaco, WA, AUS, 6008
Invex Therapeutics Ltd is a biopharmaceutical company, focused on the research and development of Exenatide as a treatment for neurological conditions such as Idiopathic Intracranial Hypertension (IIH), traumatic brain injury, or acute stroke. Its other program under development is Presendin which can be used for disabling headaches and permanent vision loss in females. Geographically, it operates only in Australia.

Invex Therapeutics (ASX:IXC) Headlines

From GuruFocus

Verger Capital Management LLC Buys iShares Global Energy ETF, iShares Gold Trust

By GuruFocus Research GuruFocus Editor 10-29-2021

Fisher Asset Management Trims Infosys, Equinor Positions

By Tiziano Frateschi Tiziano Frateschi 02-07-2021

Ken Fisher's Top 4th-Quarter Trades

By Graham Griffin Graham Griffin 02-01-2021